William Hicks

Bill advises US, UK and EU life sciences companies, investment banks and investors on capital markets, M&A, and strategic transactions. He leads IPOs, reverse mergers, sign & close reverse mergers, APOs, cross over rounds, follow on public offerings, PIPEs, registered directs, and other structured financings. He also counsels public companies on SEC compliance, governance, and ongoing corporate matters.